ArticleFrontiers in oncology2021

Immune Checkpoint Inhibitors Plus Single-Agent Chemotherapy for Advanced Non-Small-Cell Lung Cancer After Resistance to EGFR-TKI.

Haiyi Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.